共 1108 条
[1]
Xu Z(2020)Pathological findings of COVID-19 associated with acute respiratory distress syndrome Lancet Respir Med 8 420-422
[2]
Shi L(2021)Understanding COVID-19 in Wuhan from the perspective of cold-dampness: clinical evidences and mechanisms Front Med (Lausanne) 8 617659-472
[3]
Wang Y(2023)Effect of Lianhua Qingwen capsules on the positive rate of COVID-19 close contacts: a retrospective analysis of a large-scale population-based cohort study Phytomedicine 112 154690-3198
[4]
Zhang J(2022)Jinhua Qinggan granules for non–hospitalized COVID-19 patients: a double–blind, placebo-controlled, and randomized controlled trial Front Med (Lausanne) 9 928468-1098
[5]
Huang L(2020)Effect of Jinhua Qinggan granules on novel coronavirus pneumonia in patients J Tradit Chin Med 40 467-759
[6]
Zhang C(2022)Initial observations of Jinhua Qinggan Granules, a Chinese medicine, in the mitigation of hospitalization and mortality in high–risk elderly with COVID-19 infection: a retrospective study in an old age home in Hong Kong Front Med (Lausanne) 9 948149-1092
[7]
Liu S(2020)Real-world clinical study of traditional Chinese medicine treatment for 749 patients with coronavirus disease 2019 Chin J Tradit Chin Med Pharm (Zhonghua Zhong Yi Yao Za Zhi) 35 3194-1153
[8]
Zhao P(2020)Hanshiyi Formula, a medicine for Sars-CoV2 infection in China, reduced the proportion of mild and moderate COVID-19 patients turning to severe status: a cohort study Pharmacol Res 161 105127-761
[9]
Liu H(2022)Timely treatment and higher compliance to traditional Chinese medicine: new influencing factors for reducing severe COVID-19 based on retrospective cohorts in 2020 and 2021 Pharmacol Res 178 106174-246
[10]
Zhu L(2021)Clinical efficacy evaluation of Xuanfei-Baidu granules in the treatment of novel coronavirus pneumonia infected with Omicron strain Tianjin J Tradit Chin Med (Tianjin Zhong Yi Yao) 39 1093-7478